CHICAGO (Reuters) - Boston Scientific Corp is preparing another round of job cuts and planning to break up its biggest business, cardiac devices, reversing some of the restructuring put in place by ...
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results